Literature DB >> 12600892

Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes.

Carmen Perez-Terzic1, Atta Behfar, Annabelle Méry, Jan M A van Deursen, Andre Terzic, Michel Pucéat.   

Abstract

Macromolecules are transported in and out of the nucleus through nuclear pores. It is poorly understood how these megadalton conduits support nucleocytoplasmic traffic during genetic reprogramming associated with cell commitment to a specific lineage. Murine embryonic stem cells were differentiated into cardiomyocytes within embryoid bodies, and contracting cells expressing myocardial-specific proteins were isolated from the mesodermal layer. Compared with postmitotic cardiac cells from heart muscle, these proliferative and differentiating stem cell-derived cardiomyocytes demonstrated a significantly lower density of nuclear pores. At nanoscale resolution, the pore channel was commonly unoccupied in heart muscle-isolated cardiac cells, yet a dense material, presumably the central transporter, protruded toward the cytosolic face of the nuclear pore complex in stem cell-derived cardiomyocytes. Stem cell-derived cardiac cells distributed the nuclear transport factor Ran in the nucleus, decreased the number of spare nuclear pore complexes from the cytosolic annulate lamellae reservoir, and expressed a set of nucleoporins, NUP214, NUP358, NUP153, and p62, involved in nuclear transport. Stem cell-derived cardiomyocytes secured transport of nuclear constitutive proteins, cardiogenic transcription factors, and cell cycle regulators, including the prototypic histone H1, myocyte enhancer binding factor 2, and p53. Thus, differentiating stem cell-derived cardiomyocytes undergo structural adaptation and mobilize nuclear transport regulators in support of nucleocytoplasmic communication during commitment to mature cardiac lineage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12600892     DOI: 10.1161/01.RES.0000059415.25070.54

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  29 in total

1.  The human embryonic stem cell proteome revealed by multidimensional fractionation followed by tandem mass spectrometry.

Authors:  Peng Zhao; Thomas C Schulz; Eric S Sherrer; D Brent Weatherly; Allan J Robins; Lance Wells
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

2.  Cardiac transcription factors driven lineage-specification of adult stem cells.

Authors:  Ana Armiñán; Carolina Gandía; José Manuel García-Verdugo; Elisa Lledó; José Luis Mullor; José Anastasio Montero; Pilar Sepúlveda
Journal:  J Cardiovasc Transl Res       Date:  2009-10-21       Impact factor: 4.132

3.  Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction.

Authors:  Atta Behfar; Satsuki Yamada; Ruben Crespo-Diaz; Jonathan J Nesbitt; Lois A Rowe; Carmen Perez-Terzic; Vinciane Gaussin; Christian Homsy; Jozef Bartunek; Andre Terzic
Journal:  J Am Coll Cardiol       Date:  2010-08-24       Impact factor: 24.094

4.  Decoded calreticulin-deficient embryonic stem cell transcriptome resolves latent cardiophenotype.

Authors:  Randolph S Faustino; Anca Chiriac; Nicolas J Niederlander; Timothy J Nelson; Atta Behfar; Prasanna K Mishra; Slobodan Macura; Marek Michalak; Andre Terzic; Carmen Perez-Terzic
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

5.  Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells.

Authors:  Susan Chung; Petras P Dzeja; Randolph S Faustino; Carmen Perez-Terzic; Atta Behfar; Andre Terzic
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2007-02

6.  Interaction of asymmetric ABCC9-encoded nucleotide binding domains determines KATP channel SUR2A catalytic activity.

Authors:  Sungjo Park; Bernard B C Lim; Carmen Perez-Terzic; Georges Mer; Andre Terzic
Journal:  J Proteome Res       Date:  2008-03-01       Impact factor: 4.466

Review 7.  Biology and biophysics of the nuclear pore complex and its components.

Authors:  Roderick Y H Lim; Katharine S Ullman; Birthe Fahrenkrog
Journal:  Int Rev Cell Mol Biol       Date:  2008       Impact factor: 6.813

8.  c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.

Authors:  Almudena Martinez-Fernandez; Timothy J Nelson; Yasuhiro Ikeda; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2010-02       Impact factor: 4.132

9.  Developmental restructuring of the creatine kinase system integrates mitochondrial energetics with stem cell cardiogenesis.

Authors:  Susan Chung; Petras P Dzeja; Randolph S Faustino; Andre Terzic
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

10.  Embryonic stem cell therapy of heart failure in genetic cardiomyopathy.

Authors:  Satsuki Yamada; Timothy J Nelson; Ruben J Crespo-Diaz; Carmen Perez-Terzic; Xiao-Ke Liu; Takashi Miki; Susumu Seino; Atta Behfar; Andre Terzic
Journal:  Stem Cells       Date:  2008-07-31       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.